vs
MID PENN BANCORP INC（MPB）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是MID PENN BANCORP INC的1.2倍（$75.5M vs $62.0M），MID PENN BANCORP INC同比增速更快（30.8% vs 27.7%），MID PENN BANCORP INC自由现金流更多（$71.8M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 21.1%）
该资料实际介绍的是1973年成立于新泽西州切里希尔的商业银行，该银行在2007年被多伦多道明银行收购，并入其旗下的TD Banknorth，之后TD Banknorth统一更名为TD银行。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
MPB vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.2倍
$62.0M
营收增速更快
MPB
高出3.1%
27.7%
自由现金流更多
MPB
多$57.4M
$14.4M
两年增速更快
PBYI
近两年复合增速
21.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.0M | $75.5M |
| 净利润 | $19.4M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 43.6% | 22.7% |
| 净利率 | 31.4% | — |
| 营收同比 | 30.8% | 27.7% |
| 净利润同比 | 47.0% | — |
| 每股收益（稀释后） | $0.83 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MPBPBYI
| Q4 25 | $62.0M | $75.5M | ||
| Q3 25 | $61.8M | $54.5M | ||
| Q2 25 | $54.3M | $52.4M | ||
| Q1 25 | $47.7M | $46.0M | ||
| Q4 24 | $47.4M | $59.1M | ||
| Q3 24 | $45.3M | $80.5M | ||
| Q2 24 | $44.1M | $47.1M | ||
| Q1 24 | $42.3M | $43.8M |
净利润MPBPBYI
| Q4 25 | $19.4M | — | ||
| Q3 25 | $18.3M | $8.8M | ||
| Q2 25 | $4.8M | $5.9M | ||
| Q1 25 | $13.7M | $3.0M | ||
| Q4 24 | $13.2M | — | ||
| Q3 24 | $12.3M | $20.3M | ||
| Q2 24 | $11.8M | $-4.5M | ||
| Q1 24 | $12.1M | $-4.8M |
毛利率MPBPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率MPBPBYI
| Q4 25 | 43.6% | 22.7% | ||
| Q3 25 | 39.3% | 17.6% | ||
| Q2 25 | 7.9% | 12.7% | ||
| Q1 25 | 35.2% | 8.7% | ||
| Q4 24 | 34.1% | 22.6% | ||
| Q3 24 | 32.8% | 27.4% | ||
| Q2 24 | 32.4% | -4.6% | ||
| Q1 24 | 34.8% | -5.3% |
净利率MPBPBYI
| Q4 25 | 31.4% | — | ||
| Q3 25 | 29.6% | 16.2% | ||
| Q2 25 | 8.8% | 11.2% | ||
| Q1 25 | 28.8% | 6.5% | ||
| Q4 24 | 27.9% | — | ||
| Q3 24 | 27.1% | 25.2% | ||
| Q2 24 | 26.7% | -9.6% | ||
| Q1 24 | 28.7% | -11.0% |
每股收益（稀释后）MPBPBYI
| Q4 25 | $0.83 | $0.26 | ||
| Q3 25 | $0.79 | $0.17 | ||
| Q2 25 | $0.22 | $0.12 | ||
| Q1 25 | $0.71 | $0.06 | ||
| Q4 24 | $0.72 | $0.40 | ||
| Q3 24 | $0.74 | $0.41 | ||
| Q2 24 | $0.71 | $-0.09 | ||
| Q1 24 | $0.73 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $814.1M | $130.3M |
| 总资产 | $6.1B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资MPBPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务MPBPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益MPBPBYI
| Q4 25 | $814.1M | $130.3M | ||
| Q3 25 | $796.3M | $115.3M | ||
| Q2 25 | $775.7M | $104.7M | ||
| Q1 25 | $667.9M | $97.1M | ||
| Q4 24 | $655.0M | $92.1M | ||
| Q3 24 | $573.1M | $71.1M | ||
| Q2 24 | $559.7M | $48.5M | ||
| Q1 24 | $551.0M | $51.0M |
总资产MPBPBYI
| Q4 25 | $6.1B | $216.3M | ||
| Q3 25 | $6.3B | $202.9M | ||
| Q2 25 | $6.4B | $194.9M | ||
| Q1 25 | $5.5B | $196.2M | ||
| Q4 24 | $5.5B | $213.3M | ||
| Q3 24 | $5.5B | $220.7M | ||
| Q2 24 | $5.4B | $205.0M | ||
| Q1 24 | $5.3B | $214.1M |
负债/权益比MPBPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $80.0M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $71.8M | $14.4M |
| 自由现金流率自由现金流/营收 | 115.8% | 19.1% |
| 资本支出强度资本支出/营收 | 13.3% | 0.0% |
| 现金转化率经营现金流/净利润 | 4.12× | — |
| 过去12个月自由现金流最近4个季度 | $132.1M | $41.7M |
8季度趋势，按日历期对齐
经营现金流MPBPBYI
| Q4 25 | $80.0M | $14.4M | ||
| Q3 25 | $26.3M | $9.7M | ||
| Q2 25 | $29.0M | $14.1M | ||
| Q1 25 | $11.5M | $3.6M | ||
| Q4 24 | $51.4M | $15.6M | ||
| Q3 24 | $16.9M | $11.0M | ||
| Q2 24 | $18.0M | $1.0M | ||
| Q1 24 | $12.4M | $11.2M |
自由现金流MPBPBYI
| Q4 25 | $71.8M | $14.4M | ||
| Q3 25 | $24.3M | $9.7M | ||
| Q2 25 | $27.2M | $14.1M | ||
| Q1 25 | $8.8M | $3.6M | ||
| Q4 24 | $44.5M | $15.6M | ||
| Q3 24 | $16.8M | $11.0M | ||
| Q2 24 | $17.7M | $1.0M | ||
| Q1 24 | $12.1M | — |
自由现金流率MPBPBYI
| Q4 25 | 115.8% | 19.1% | ||
| Q3 25 | 39.4% | 17.7% | ||
| Q2 25 | 50.1% | 26.8% | ||
| Q1 25 | 18.4% | 7.7% | ||
| Q4 24 | 93.8% | 26.4% | ||
| Q3 24 | 37.1% | 13.7% | ||
| Q2 24 | 40.2% | 2.1% | ||
| Q1 24 | 28.5% | — |
资本支出强度MPBPBYI
| Q4 25 | 13.3% | 0.0% | ||
| Q3 25 | 3.1% | 0.0% | ||
| Q2 25 | 3.2% | 0.0% | ||
| Q1 25 | 5.7% | 0.1% | ||
| Q4 24 | 14.6% | 0.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.7% | 0.0% | ||
| Q1 24 | 0.8% | 0.0% |
现金转化率MPBPBYI
| Q4 25 | 4.12× | — | ||
| Q3 25 | 1.44× | 1.10× | ||
| Q2 25 | 6.08× | 2.41× | ||
| Q1 25 | 0.84× | 1.21× | ||
| Q4 24 | 3.88× | — | ||
| Q3 24 | 1.37× | 0.54× | ||
| Q2 24 | 1.53× | — | ||
| Q1 24 | 1.02× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
